Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serine ADP-ribosylation in DNA-damage response regulation
Luca Palazzo, Marcin J. Suskiewicz, Ivan Ahel
Current Opinion in Genetics & Development (2021) Vol. 71, pp. 106-113
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health
Roberto Campagna, Arianna Vignini
Antioxidants (2023) Vol. 12, Iss. 2, pp. 376-376
Open Access | Times Cited: 42
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
N Mimica Dukic, Øyvind Strømland, Jonas D. Elsborg, et al.
Science Advances (2023) Vol. 9, Iss. 37
Open Access | Times Cited: 38
Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection
Julie Rageul, Natalie Lo, Amy L Phi, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113845-113845
Open Access | Times Cited: 10
NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage
Josune Alonso‐Marañón, Laura Solé, Daniel Álvarez‐Villanueva, et al.
Science Signaling (2025) Vol. 18, Iss. 877
Closed Access | Times Cited: 1
Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling
Pietro Fontana, Sara C. Buch-Larsen, Osamu Suyari, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Free radical biology in neurological manifestations: mechanisms to therapeutics interventions
Rahul Tripathi, Rohan Gupta, Mehar Sahu, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62160-62207
Closed Access | Times Cited: 35
Beyond protein modification: the rise of non-canonical ADP-ribosylation
M. Schuller, Ivan Ahel
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 463-477
Open Access | Times Cited: 27
Influence of chain length and branching on poly(ADP-ribose)–protein interactions
Tobias Löffler, Annika Krüger, Peyman Zirak, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 2, pp. 536-552
Open Access | Times Cited: 11
PARP1: A comprehensive review of its mechanisms, therapeutic implications and emerging cancer treatments
Carlota J.F. Conceição, Elin Moe, Paulo A. Ribeiro, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189282-189282
Open Access
NAD+ metabolism and therapeutic strategies in cardiovascular diseases
Chongxu Shi, Zhaozhi Wen, Yihang Yang, et al.
Atherosclerosis Plus (2024) Vol. 57, pp. 1-12
Open Access | Times Cited: 3
Mimetics of ADP-Ribosylated Histidine through Copper(I)-Catalyzed Click Chemistry
Hugo Minnee, J.G.M. Rack, Gijsbert A. van der Marel, et al.
Organic Letters (2022) Vol. 24, Iss. 21, pp. 3776-3780
Open Access | Times Cited: 14
Progress towards a standardized model of ocular sulfur mustard injury for therapeutic testing
Patrick McNutt
Experimental Eye Research (2023) Vol. 228, pp. 109395-109395
Open Access | Times Cited: 8
The function and regulation of ADP-ribosylation in the DNA damage response
Lena Duma, Ivan Ahel
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 995-1008
Open Access | Times Cited: 8
The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors
Adèle Beneyton, Louis Nonfoux, Jean‐Philippe Gagné, et al.
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 6
Are PARPs promiscuous?
Karla L. H. Feijs, Roko Žaja
Bioscience Reports (2022) Vol. 42, Iss. 5
Open Access | Times Cited: 8
The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma
Francesco Morra, Francesco Merolla, Giovanna Damia, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 8
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
N Mimica Dukic, Øyvind Strømland, Deeksha Munnur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Using TLC-MALDI-TOF to Interrogate In Vitro Peptidyl Proximal Preferences of PARP14 and Glycohydrolase Specificity
Zeeshan Javed, Hannah H. Nguyen, Kiana K. Harker, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6061-6061
Open Access | Times Cited: 2
Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?)
Anthony Sanchez, Bethany A. Buck‐Koehntop, Kyle M. Miller
BioEssays (2022) Vol. 44, Iss. 7
Open Access | Times Cited: 3
Microglial inflammation in genome instability: A neurodegenerative perspective
Nina Maliar, Emily Talbot, A. Edwards, et al.
DNA repair (2024) Vol. 135, pp. 103634-103634
Open Access
Novel heterozygous variant of ADPRHL2 causes pathogenic variation in CONDSIAS
Shuang Yan, Jie Ren, Hongting Su, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e32945-e32945
Open Access
A New Approach for Studying Poly(ADP-Ribose) Polymerase Inhibitors Using Permeabilized Adherent Cells
С. И. Шрам, Tatyana A. Shcherbakova, Tatyana V. Abramova, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 9, pp. 1619-1630
Closed Access
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents
Rocco Caggiano, Evgeniia Prokhorova, Lena Duma, et al.
Neoplasia (2024) Vol. 59, pp. 101092-101092
Closed Access
Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegeneration
Lyndsay Hastings, Arpine Sokratian, Daniel J. Apicco, et al.
Brain Communications (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 2
The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation
Celeste Giansanti
(2023)
Open Access
Page 1 - Next Page

Scroll to top